NAMPT overexpression confers resistance to specific drugs (chemotherapeutic agents and selective kinase inhibitors) in several tumor models, including glioma [174], colon cancer [175], sarcoma [176], breast cancer [177,178], and melanoma [160,179], as detailed in the next paragraph. Here, NAMPT is linked to melanoma.